Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation

ABSTRACT: Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation

PROVIDER: PRJNA487068 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response I

Project description:The purpose of this study was to define biomarkers of sensitivty and mechanisms of resistance to the KDM1A/LSD1 inhibtor SP-2509 (HCI-2509) in Ewing sarcoma cell lines. We report that regardless of drug sensitivity all cell lines engage the UPR and ER-stress response following treatment with SP-2509 resulting in apoptotic cytotoxicity. In addition hypersentsitive cell lines shared a common basal transcriptnomic profile, with hypersensitive cell lines signficantly inducing ETS1 which was not observed in sensitive cell lines.

2019-05-03 | GSE98785 | GEO

Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II

Project description:The transcriptional profile of LSD1 knockdown in A673 Ewing sarcoma cells mirrors that of EWS/FLI knockdown and LSD1 small molecule inhibition (SP-2509)

2019-05-03 | GSE98786 | GEO

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II

Project description:Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II

| PRJNA487073 | ENA

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I

Project description:Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I

| PRJNA487071 | ENA

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I

Project description:The transcriptional profile of A673 parental and SP-2509 Drug resistant cells treated with DMSO and SP-2509 (2uM 48hrs)

2018-12-26 | GSE118864 | GEO

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II

Project description:The transcriptional profile of A673 parental, and SP-2509 drug resistant washout cells (4 and 6 months)

2018-12-26 | GSE118870 | GEO

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation.

Project description: Not available

| S-EPMC6284858 | biostudies-literature

Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response

Project description:Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response

| PRJNA386197 | ENA

RNA sequencing of A673 and monoclonal KO cells treated with DMSO or SP-2509

Project description:RNA sequencing data for a Ewing sarcoma cell line, A673 treated with DMSO or the LSD1 inhibitor, SP-2509. Monoclonal cell lines were generated by CRISPR/Cas9 mediated KO of mitochondrial genes MRPL45, UQCRFS1, and CYC1. These cells were treated with DMSO or SP-2509 to determine mitochondrial gene KO derived drug resistance.

2022-04-05 | GSE185379 | GEO

Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.

Project description: Not available

| S-EPMC6201274 | biostudies-literature